References
- WestenbergHGFinebergNADenysDNeurobiology of obsessive-compulsive disorder: serotonin and beyondCNS Spectr200723142717277720
- LeeMACameronOGGurguisGNAlpha 2-adrenoreceptor status in obsessive-compulsive disorderBiol Psychiatry19902710108310932160292
- McDougleCJBarrLCGoodmanWKPriceLHPossible role of neuropeptides in obsessive compulsive disorderPsychoneuroendocrinology199924112410098217
- BhattacharyyaSChakrabortyKGlutamatergic dysfunction – newer targets for anti-obsessional drugsRecent Patents CNS Drug Discov2007214755
- LeckmanJFGoodmanWKAndersonGMCerebrospinal fluid biogenic amines in obsessive compulsive disorder, Tourette’s syndrome, and healthy controlsNeuropsychopharmacology199512173867766289
- HollanderEDeCariaCNitescuANoradrenergic function in obsessive-compulsive disorder: behavioral and neuroendocrine responses to clonidine and comparison to healthy controlsPsychiatry Res19913721611771876628
- MarazzitiDBaroniSMasalaIPlatelet alpha2-adrenoreceptors in obsessive-compulsive disorderNeuropsychobiology2004492818314981338
- PallantiSQuercioliLBruscoliMResponse acceleration with mirtazapine augmentation of citalopram in obsessive-compulsive disorder patients without comorbid depression: a pilot studyJ Clin Psychiatry200465101394139915491244
- LeschKPWolozinBLMurphyDLRiedererPPrimary structure of the human platelet serotonin uptake: identity with the brain serotonin transporterJ Neurochem199360231923227684072
- MarazzitiDRossiAGemignaniADecreased platelet 3H-paroxetine binding in obsessive-compulsive patientsNeuropsychobiology1996341841879121618
- StahlSMEssential Psychopharmacology: Neuroscientific Basic and Practical ApplicationsCambridge University Press2008
- MarazzitiDPerezJCassanoGBIs obsessive-compulsive disorder caused by a second-messenger imbalance?CNS Spectr20016320620916951654
- JohnsonRAAlvarezRSalomonYDetermination of adenylyl cyclase catalytic activity using single and double column proceduresMeth Enzymol199423831567799798
- FirstMBSpitzerRLGibbonMWilliamsJBWStructured Clinical interview for DSM-IV Axis I disorders - Patient Edition (SCID-I/P, Version 2.0)New York, NYBiometrics Research Department, New York State Psychiatric Institute1995
- GoodmanWKPriceLHRasmussenRAThe Yale-Brown Obsessive Compulsive Scale: I. Development Use and ReliabilityArch Gen Psychiatry198946100610112684084
- HamiltonMA rating scale for depressionJ Neurol Neurosurg Psychiatry196023566214399272
- FangerBOAdaptation of the Bradford protein assay to membrane-bound proteins by solubilizing in glucopyranoside detergentsAnal Biochemistry198716211117
- Dell’OssoLCarmassiCPalegoLSerotonin-mediated cyclic AMP inhibitory pathway in platelets of patients affected by panic disorderNeuropsychobiology2004501283615179017
- KerryRScruttonMCPlatelet beta-adrenoceptorsBr J Pharmacol19837936816916140045
- WintherKKlysnerRGeislerAAndersenPHCharacterization of human platelet beta-adrenoceptorsThromb Res19854067577673003961
- HedmanCWintherKKnudsenJBPlatelet function in classic migraine during attack-free periodsActa Neurol Scand19887842712772851913
- HollisterASFitzGeraldGANadeauJHRobertsonDAcute reduction in human plateletalpha 2-adrenoreceptor affinity for agonist by endogenous and exogenous catecholaminesJ Clin Invest1983724149815056138365
- PerezJTarditoDRavizzaLRacagniGMoriSMainaGAltered cAMP-dependent protein kinase A in platelets of patients with obsessive-compulsive disorderAm J Psychiatry2000157228428610671404